Kampala, Uganda | Patricia Akankwatsa | On June 23, Novartis endorsed the Kigali Declaration on neglected tropical diseases (NTDs) and announced a five-year financial commitment of $250 million to fight against NTDs and malaria in conjunction with the Kigali Summit on Malaria and NTDs alongside the 26th Commonwealth Heads of Government …
Read More »Novartis to inject $100 mn into malaria drug research
Zurich, Switzerland | AFP | Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. There were some 216 million cases of malaria worldwide in …
Read More »Norvatis brings cheaper cancer, high blood pressure drugs
Novartis a global healthcare company based in Switzerland recently signed a Memorandum of Understanding (MOU) with the Ministry of Health to supply the country with, among others, cancer drugs. The Independent’s Flavia Nassaka spoke to Dr. Nathan Mulure, Cluster Head Norvatis Social Business for East and Southern Africa during …
Read More »